Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy

Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy

US Patent 10111962 · Granted Oct 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muscle targeting complexes and uses thereof for treating myotonic dystrophy2025
United states2025
Modulation of dystrophia myotonica-protein kinase (DMPK) expression2025
Modulation of dystrophia myotonica-protein kinase (DMPK) expression2025
Modulation of dystrophia myotonica-protein kinase (DMPK) expression2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonuc2025
Muscle targeting complexes and formulations for treating myotonic dystrophy2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonic2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonuc2025